Prolonged indolent clinical course in a high-risk chronic phase-CML patient without cytogenetic or molecular response: a case challenging established response paradigms.

Longo E, Markovic U, Stella S, Antolino A, Massimino M, Fazio M, Di Raimondo F, Allegra A, Stagno F

Open source

DOI
10.1007/s00277-026-07233-4
Published
2026 Aug 10
Container
Annals of hematology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00277-026-07233-4,
  title = {Prolonged indolent clinical course in a high-risk chronic phase-CML patient without cytogenetic or molecular response: a case challenging established response paradigms.},
  author = {Longo E and Markovic U and Stella S and Antolino A and Massimino M and Fazio M and Di Raimondo F and Allegra A and Stagno F},
  year = {2026},
  journal = {Annals of hematology},
  doi = {10.1007/s00277-026-07233-4},
  url = {https://doi.org/10.1007/s00277-026-07233-4}
}

RIS

TY  - JOUR
TI  - Prolonged indolent clinical course in a high-risk chronic phase-CML patient without cytogenetic or molecular response: a case challenging established response paradigms.
AU  - Longo E
AU  - Markovic U
AU  - Stella S
AU  - Antolino A
AU  - Massimino M
AU  - Fazio M
AU  - Di Raimondo F
AU  - Allegra A
AU  - Stagno F
PY  - 2026
JO  - Annals of hematology
DO  - 10.1007/s00277-026-07233-4
UR  - https://doi.org/10.1007/s00277-026-07233-4
ER  - 

APA

E, L., U, M., S, S., A, A., M, M., M, F., F, D. R., A, A., & F, S. (2026). Prolonged indolent clinical course in a high-risk chronic phase-CML patient without cytogenetic or molecular response: a case challenging established response paradigms.. Annals of hematology. https://doi.org/10.1007/s00277-026-07233-4

Source records